Health Care
America has the most advanced health care in the world, in large part due to private sector-led innovation and employer-sponsored healthcare coverage.
While Americans benefit tremendously from ongoing advancements in bioscience, technology, and care, we continue to wrestle with the challenge of making quality health care more affordable, more accessible, and more reliable for all Americans. At the U.S. Chamber, we’re pushing for value-based healthcare solutions that reduce costs and reward quality outcomes.
Latest
Report
The United States is currently grappling with a nursing shortage that is causing a ripple effect of rising health care costs and lower quality of life across the country.
Spotlight on Mental Health
Become a part of the world’s largest business organization and network
U.S. Chamber members range from small businesses and chambers of commerce across the country to startups in fast-growing sectors, leading industry associations, and global corporations.
Discover the ROI Chamber membership can deliver for you.
Our Work
The U.S. Chamber is promoting effective private sector solutions to our health care challenges. These solutions will help control costs, expand access, and improve the quality of care. We support policy that strengthens the employer-based model of coverage, through which 180 million Americans receive—and overwhelmingly like—their health care.
Related Litigation
Events
Latest Content
This joint trades letter was sent to all members of the United States Senate applauding the introduction of the Better Care Reconciliation Act of 2017.
There a lot that’s good in the “Better Care Reconciliation Act.”
U.S. Chamber of Commerce President and CEO Thomas J. Donohue issued the following statement today upon the release of the Senate discussion draft on health care:
Technology and innovation have been instrumental in propelling health care forward.
The health care reform ball is in the Senate’s court. Over the last few weeks, a working group has been hashing out a plan to repeal and replace Obamacare.
On Tuesday, June 6, 2017, this letter was sent to the members of the House Energy and Commerce Committee opposing any amendments that may be offered to H.R. 2430, the FDA Reauthorization Act (FDARA) of 2017, that would allow the importation of foreign pharmaceuticals into the United States or that would undermine the preemptive authority of federal food and drug regulations. The Committee will mark up the bill tomorrow morning. June 6, 2017 Dear Chairman Walden and Ranking Member Pallone:
On May 23, 2017, the U.S. Chamber of Commerce sent this letter to Senate Finance Committee Chairman Orrin Hatch that outlined several legislative reform recommendations as the Senate moves forward with crafting their own proposal for the repeal and replacement of Obamacare.
Consumers who buy their own insurance may soon be forced out of the market.
On Friday, May 19, the Chamber, along with 7 other trade associations representing insurers, hospitals, physicians and employers, sent a letter to U.S. Department of Health and Human Services Secretary Tom Price. The letter outlines serious concerns about the continued uncertainty around funding for cost-sharing reduction (CSR) payments and the negative impacts uncertainty will have on millions of Americans if it is not addressed.
On Friday, May 19, the Chamber, along with 7 additional trade associations representing insurers, hospitals, physicians and employers, sent a letter to Office of Management and Budget Director Mick Mulvaney. The letter outlines serious concerns about the continued uncertainty around funding for cost-sharing reduction (CSR) payments and the negative impacts uncertainty will have on millions of Americans if it is not addressed.
